載入...
Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
Chimeric antigen receptor–modified T cells with specificity for CD19 have shown promise in the treatment of chronic lymphocytic leukemia (CLL). It remains to be established whether chimeric antigen receptor T cells have clinical activity in acute lymphoblastic leukemia (ALL). Two children with relap...
Na minha lista:
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2013
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4058440/ https://ncbi.nlm.nih.gov/pubmed/23527958 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1215134 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|